A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance
Preprint
Abstract
The virus SARS-CoV-2 can exploit biological vulnerabilities in susceptible hosts that predispose to development of severe COVID-19. Previous reports have identified several host proteins related to the interferon response (e.g. OAS1), interleukin-6 signalling (IL-6R), and the coagulation cascade (linked via ABO) that were associated with risk of COVID-19. In the present study, we performed proteome-wide genetic colocalisation tests leveraging publicly available protein and COVID-19 datasets, to identify additional proteins that may contribute to COVID-19 risk. Our analytic approach identified several known targets (e.g. ABO, OAS1), but also nominated new proteins such as soluble FAS (colocalisation probability > 0.9, p = 1 × 10 −4 ), implicating FAS-mediated apoptosis as a potential target for COVID-19 risk. We also undertook polygenic (pan) and cis-Mendelian randomisation analyses that showed consistent associations of genetically predicted ABO protein with several COVID-19 phenotypes. The ABO signal was associated with plasma concentrations of several proteins, with the strongest association observed with CD209 in several proteomic datasets. We demonstrated experimentally that CD209 directly interacts with the spike protein of SARS-CoV-2, suggesting a mechanism that could explain the ABO association with COVID-19. Our work provides a prioritised list of host targets potentially exploited by SARS-CoV-2 and is a precursor for further research on CD209 and FAS as therapeutically tractable targets for COVID-19.Keywords
All Related Versions
- Published version: eLife, 10.
This publication has 58 references indexed in Scilit:
- Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic datamedRxiv, 2021
- Mining a GWAS of Severe Covid-19New England Journal of Medicine, 2020
- Genetic mechanisms of critical illness in COVID-19Nature, 2020
- A Neanderthal OAS1 isoform Protects Against COVID-19 Susceptibility and Severity: Results from Mendelian Randomization and Case-Control StudiesmedRxiv, 2020
- Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseasesNature Genetics, 2020
- The current landscape of coronavirus-host protein–protein interactionsJournal of Translational Medicine, 2020
- The Global Phosphorylation Landscape of SARS-CoV-2 InfectionCell, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposingNature, 2020
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for cliniciansBMJ, 2018